
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $42M | $55.1M | $60M | $63.8M | $50.4M | |
Revenue Growth (YoY) | 12.07% | 31.2% | 8.78% | 6.3% | -20.96% | |
Cost of Revenues | $23.9M | $22.1M | $26M | $26.5M | $24.3M | |
Gross Profit | $18.1M | $33.1M | $33.9M | $37.2M | $26.1M | |
Gross Profit Margin | 43.04% | 59.97% | 56.59% | 58.41% | 51.84% | |
R&D Expenses | $10.9M | $12.6M | $11.1M | $11.8M | $13.7M | |
Selling, General & Admin | $14.8M | $15.4M | $16.6M | $19.6M | $19.5M | |
Other Inc / (Exp) | -$24K | -$141K | $190K | $3.2M | $7.8M | |
Operating Expenses | $25.7M | $28M | $27.7M | $31.4M | $33.2M | |
Operating Income | -$7.6M | $5M | $6.2M | $5.9M | -$7.1M | |
Net Interest Expenses | $665K | $547K | $274K | $63K | -- | |
EBT. Incl. Unusual Items | -$8.3M | $4.3M | $6.1M | $9M | $741K | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $260K | $4K | $14K | -$16K | -$40K | |
Net Income to Company | -$8.5M | $4.3M | $6.1M | $9.1M | $781K | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$8.5M | $4.3M | $6.1M | $9.1M | $781K | |
Basic EPS (Cont. Ops) | -$0.45 | $0.22 | $0.30 | $0.44 | $0.04 | |
Diluted EPS (Cont. Ops) | -$0.45 | $0.22 | $0.29 | $0.42 | $0.04 | |
Weighted Average Basic Share | $18.8M | $19.4M | $20.1M | $20.7M | $21.6M | |
Weighted Average Diluted Share | $18.8M | $20M | $20.8M | $21.4M | $22.2M | |
EBITDA | -$5.6M | $6.3M | $7.4M | $10.3M | $2.5M | |
EBIT | -$7.6M | $4.9M | $6.4M | $9.1M | $741K | |
Revenue (Reported) | $42M | $55.1M | $60M | $63.8M | $50.4M | |
Operating Income (Reported) | -$7.6M | $5M | $6.2M | $5.9M | -$7.1M | |
Operating Income (Adjusted) | -$7.6M | $4.9M | $6.4M | $9.1M | $741K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $10.3M | $14.3M | $14.8M | $14.4M | $13.1M | |
Revenue Growth (YoY) | 1.7% | 39.56% | 3.48% | -2.8% | -8.95% | |
Cost of Revenues | $4.3M | $6M | $6.4M | $6.3M | $6.4M | |
Gross Profit | $6M | $8.3M | $8.4M | $8.2M | $6.8M | |
Gross Profit Margin | 58.22% | 58.01% | 56.78% | 56.55% | 51.4% | |
R&D Expenses | $2.4M | $2.4M | $3.2M | $3.4M | $3.4M | |
Selling, General & Admin | $3.8M | $3.9M | $4.5M | $5.3M | $5.3M | |
Other Inc / (Exp) | -$15K | -$14K | $128K | -$41K | $388K | |
Operating Expenses | $6.3M | $6.3M | $7.7M | $8.8M | $8.7M | |
Operating Income | -$284K | $2M | $696K | -$600K | -$1.9M | |
Net Interest Expenses | $152K | $75K | $63K | -- | -- | |
EBT. Incl. Unusual Items | -$451K | $1.9M | $761K | -$202K | -$1.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $9K | -- | -- | -- | $30K | |
Net Income to Company | -$460K | $1.9M | $761K | -$202K | -$1.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$460K | $1.9M | $761K | -$202K | -$1.2M | |
Basic EPS (Cont. Ops) | -$0.02 | $0.10 | $0.04 | -$0.01 | -$0.05 | |
Diluted EPS (Cont. Ops) | -$0.02 | $0.09 | $0.04 | -$0.01 | -$0.05 | |
Weighted Average Basic Share | $19.1M | $19.9M | $20.5M | $21.3M | $22.2M | |
Weighted Average Diluted Share | $19.1M | $20.7M | $20.8M | $21.3M | $22.2M | |
EBITDA | $84K | $2.3M | $1.2M | -$202K | -$1.1M | |
EBIT | -$299K | $2M | $824K | -$600K | -$1.9M | |
Revenue (Reported) | $10.3M | $14.3M | $14.8M | $14.4M | $13.1M | |
Operating Income (Reported) | -$284K | $2M | $696K | -$600K | -$1.9M | |
Operating Income (Adjusted) | -$299K | $2M | $824K | -$600K | -$1.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $42.2M | $59.2M | $60.5M | $63.3M | $49.1M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $23.5M | $23.8M | $26.4M | $26.4M | $24.4M | |
Gross Profit | $18.7M | $35.4M | $34.1M | $37M | $24.7M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $10.3M | $12.6M | $11.9M | $12M | $13.6M | |
Selling, General & Admin | $14.7M | $15.4M | $17.3M | $20.4M | $19.5M | |
Other Inc / (Exp) | -$87K | -$140K | $332K | $3M | $7.8M | |
Operating Expenses | $25M | $28.1M | $29.2M | $32.4M | $33.1M | |
Operating Income | -$6.3M | $7.3M | $4.9M | $4.6M | -$8.4M | |
Net Interest Expenses | $645K | $470K | $262K | -- | -- | |
EBT. Incl. Unusual Items | -$7M | $6.7M | $5M | $8.1M | -$193K | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $243K | -- | -- | -$16K | -$10K | |
Net Income to Company | -$7.2M | $6.7M | $5M | $8.1M | -$183K | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$7.2M | $6.7M | $5M | $8.1M | -$183K | |
Basic EPS (Cont. Ops) | -$0.38 | $0.35 | $0.24 | $0.40 | -$0.01 | |
Diluted EPS (Cont. Ops) | -$0.38 | $0.33 | $0.23 | $0.37 | -$0.01 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$4.4M | $8.5M | $6.3M | $8.9M | $1.2M | |
EBIT | -$6.4M | $7.2M | $5.2M | $7.7M | -$989K | |
Revenue (Reported) | $42.2M | $59.2M | $60.5M | $63.3M | $49.1M | |
Operating Income (Reported) | -$6.3M | $7.3M | $4.9M | $4.6M | -$8.4M | |
Operating Income (Adjusted) | -$6.4M | $7.2M | $5.2M | $7.7M | -$989K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $10.3M | $14.3M | $14.8M | $14.4M | $13.1M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $4.3M | $6M | $6.4M | $6.3M | $6.4M | |
Gross Profit | $6M | $8.3M | $8.4M | $8.2M | $6.8M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $2.4M | $2.4M | $3.2M | $3.4M | $3.4M | |
Selling, General & Admin | $3.8M | $3.9M | $4.5M | $5.3M | $5.3M | |
Other Inc / (Exp) | -$15K | -$14K | $128K | -$41K | $388K | |
Operating Expenses | $6.3M | $6.3M | $7.7M | $8.8M | $8.7M | |
Operating Income | -$284K | $2M | $696K | -$600K | -$1.9M | |
Net Interest Expenses | $152K | $75K | $63K | -- | -- | |
EBT. Incl. Unusual Items | -$451K | $1.9M | $761K | -$202K | -$1.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $9K | -- | -- | -- | $30K | |
Net Income to Company | -$460K | $1.9M | $761K | -$202K | -$1.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$460K | $1.9M | $761K | -$202K | -$1.2M | |
Basic EPS (Cont. Ops) | -$0.02 | $0.10 | $0.04 | -$0.01 | -$0.05 | |
Diluted EPS (Cont. Ops) | -$0.02 | $0.09 | $0.04 | -$0.01 | -$0.05 | |
Weighted Average Basic Share | $19.1M | $19.9M | $20.5M | $21.3M | $22.2M | |
Weighted Average Diluted Share | $19.1M | $20.7M | $20.8M | $21.3M | $22.2M | |
EBITDA | $84K | $2.3M | $1.2M | -$202K | -$1.1M | |
EBIT | -$299K | $2M | $824K | -$600K | -$1.9M | |
Revenue (Reported) | $10.3M | $14.3M | $14.8M | $14.4M | $13.1M | |
Operating Income (Reported) | -$284K | $2M | $696K | -$600K | -$1.9M | |
Operating Income (Adjusted) | -$299K | $2M | $824K | -$600K | -$1.9M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $14.6M | $21.4M | $26.8M | $36.9M | $42.1M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $7.6M | $8.1M | $10.5M | $11.5M | $11.9M | |
Inventory | $5.7M | $6.4M | $6.7M | $8.4M | $9.1M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $270K | $762K | $604K | $988K | $1.3M | |
Total Current Assets | $28.2M | $36.8M | $44.7M | $57.9M | $64.2M | |
Property Plant And Equipment | $4.3M | $1.9M | $10.5M | $9.2M | $7.8M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | $3.4M | |
Other Long-Term Assets | $73K | $734K | $62K | $212K | $2.4M | |
Total Assets | $32.5M | $39.4M | $55.3M | $67.3M | $77.8M | |
Accounts Payable | $2.2M | $1.8M | $2.8M | $2.9M | $2.3M | |
Accrued Expenses | $2.2M | $3.6M | $3.5M | $4.3M | $2.4M | |
Current Portion Of Long-Term Debt | $4.2M | $3.4M | $2.6M | -- | -- | |
Current Portion Of Capital Lease Obligations | $1.5M | $724K | $1.1M | $1.2M | $1.3M | |
Other Current Liabilities | $31K | $50K | $27K | -- | $1.8M | |
Total Current Liabilities | $10.2M | $10.3M | $10.9M | $8.8M | $9.9M | |
Long-Term Debt | $3.7M | $1.5M | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $15.1M | $12.1M | $16.7M | $13.4M | $15.2M | |
Common Stock | $2K | $2K | $2K | $2K | $2K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $17.4M | $27.2M | $38.7M | $53.9M | $62.6M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $17.4M | $27.2M | $38.7M | $53.9M | $62.6M | |
Total Liabilities and Equity | $32.5M | $39.4M | $55.3M | $67.3M | $77.8M | |
Cash and Short Terms | $14.6M | $21.4M | $26.8M | $36.9M | $42.1M | |
Total Debt | $8M | $4.9M | $2.6M | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $15.5M | $19.9M | $24.2M | $34.8M | $42.2M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $9.2M | $9.8M | $11M | $13.2M | $12.8M | |
Inventory | $5.4M | $6.2M | $6.3M | $8.1M | $11M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $208K | $636K | $485K | $450K | $1M | |
Total Current Assets | $31.4M | $37M | $42.2M | $56.4M | $66.8M | |
Property Plant And Equipment | $3.6M | $4.9M | $10.1M | $9.6M | $7.9M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | $3M | |
Other Long-Term Assets | $73K | $769K | $62K | $212K | $2.6M | |
Total Assets | $35.1M | $42.7M | $52.4M | $66.2M | $80.2M | |
Accounts Payable | $1.9M | $2.3M | $2.1M | $2.4M | $3.2M | |
Accrued Expenses | $2.1M | $1.6M | $2.1M | $2.1M | $2.6M | |
Current Portion Of Long-Term Debt | $4.3M | $3.4M | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $1.4M | $942K | $1.1M | $1.3M | $1.3M | |
Other Current Liabilities | $37K | $39K | $50K | -- | $1.8M | |
Total Current Liabilities | $12.8M | $8.5M | $6.3M | $5.9M | $12.6M | |
Long-Term Debt | $3.2M | $954K | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $16.9M | $12.6M | $11.8M | $10.4M | $17.2M | |
Common Stock | $2K | $2K | $2K | $2K | $2K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $18.2M | $30.1M | $40.6M | $55.8M | $63M | |
Total Liabilities and Equity | $35.1M | $42.7M | $52.4M | $66.2M | $80.2M | |
Cash and Short Terms | $15.5M | $19.9M | $24.2M | $34.8M | $42.2M | |
Total Debt | $7.5M | $4.3M | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$8.5M | $4.3M | $6.1M | $9.1M | $781K | |
Depreciation & Amoritzation | $2M | $1.5M | $982K | $1.2M | $1.7M | |
Stock-Based Compensation | $4M | $3.2M | $4.4M | $5M | $6.7M | |
Change in Accounts Receivable | -$1.8M | -$586K | -$2.5M | -$889K | -$168K | |
Change in Inventories | $2.1M | -$675K | -$287K | -$1.7M | -$719K | |
Cash From Operations | -$2.9M | $9.4M | $9.5M | $13.1M | $7.1M | |
Capital Expenditures | $320K | $1M | $2.8M | $1.4M | $3.1M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$320K | -$1M | -$2.6M | -$1.4M | -$3.1M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$9K | -$3.4M | -$2.4M | -$2.8M | -$66K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -$11K | -$10K | -- | -- | |
Cash From Financing | $3.4M | -$1.5M | -$1.5M | -$1.6M | $1.1M | |
Beginning Cash (CF) | $14.5M | $14.6M | $21.4M | $26.8M | $36.9M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $112K | $6.8M | $5.4M | $10.2M | $5.2M | |
Ending Cash (CF) | $14.6M | $21.4M | $26.8M | $36.9M | $42.1M | |
Levered Free Cash Flow | -$3.2M | $8.3M | $6.7M | $11.7M | $4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$460K | $1.9M | $761K | -$202K | -$1.2M | |
Depreciation & Amoritzation | $383K | $258K | $333K | $398K | $846K | |
Stock-Based Compensation | $743K | $824K | $1.2M | $1.7M | $1.6M | |
Change in Accounts Receivable | -$2.7M | -$2M | -$544K | -$1.5M | -$843K | |
Change in Inventories | $363K | $188K | $404K | $338K | -$1.9M | |
Cash From Operations | $1.7M | -$971K | $1.2M | -$1.3M | $1.4M | |
Capital Expenditures | $309K | $22K | $1M | $1.2M | $1.4M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$309K | -$22K | -$1M | -$1.2M | -$1.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$600K | -$600K | -$2.8M | -- | -$17K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$456K | -$531K | -$2.8M | $353K | $12K | |
Beginning Cash (CF) | $14.6M | $21.4M | $26.8M | $36.9M | $42.1M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $886K | -$1.5M | -$2.6M | -$2.1M | $61K | |
Ending Cash (CF) | $15.5M | $19.9M | $24.2M | $34.8M | $42.2M | |
Levered Free Cash Flow | $1.3M | -$993K | $193K | -$2.5M | $49K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$7.2M | $6.7M | $5M | $8.1M | -$183K | |
Depreciation & Amoritzation | $2M | $1.3M | $1.1M | $1.3M | $2.2M | |
Stock-Based Compensation | $3.9M | $3.3M | $4.7M | $5.6M | $6.6M | |
Change in Accounts Receivable | -$4M | $75K | -$969K | -$1.9M | $513K | |
Change in Inventories | $2.6M | -$850K | -$71K | -$1.8M | -$2.9M | |
Cash From Operations | $1.3M | $6.7M | $11.7M | $10.6M | $9.8M | |
Capital Expenditures | $565K | $743K | $3.8M | $1.6M | $3.2M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$565K | -$743K | -$3.6M | -$1.6M | -$3.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$607K | -$3.4M | -$4.6M | -- | -$83K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | $817K | -$1.6M | -$3.8M | $1.5M | $771K | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $1.5M | $4.4M | $4.3M | $10.6M | $7.4M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $718K | $6M | $7.9M | $9M | $6.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$460K | $1.9M | $761K | -$202K | -$1.2M | |
Depreciation & Amoritzation | $383K | $258K | $333K | $398K | $846K | |
Stock-Based Compensation | $743K | $824K | $1.2M | $1.7M | $1.6M | |
Change in Accounts Receivable | -$2.7M | -$2M | -$544K | -$1.5M | -$843K | |
Change in Inventories | $363K | $188K | $404K | $338K | -$1.9M | |
Cash From Operations | $1.7M | -$971K | $1.2M | -$1.3M | $1.4M | |
Capital Expenditures | $309K | $22K | $1M | $1.2M | $1.4M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$309K | -$22K | -$1M | -$1.2M | -$1.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$600K | -$600K | -$2.8M | -- | -$17K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$456K | -$531K | -$2.8M | $353K | $12K | |
Beginning Cash (CF) | $14.6M | $21.4M | $26.8M | $36.9M | $42.1M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $886K | -$1.5M | -$2.6M | -$2.1M | $61K | |
Ending Cash (CF) | $15.5M | $19.9M | $24.2M | $34.8M | $42.2M | |
Levered Free Cash Flow | $1.3M | -$993K | $193K | -$2.5M | $49K |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.